Scheie Syndrome (Mucopolysaccharidosis Type IS)


Risk

  • Incidence: 1:500,000

  • Inherited as autosomal recessive

Perioperative Risks

  • Difficult intubation

  • Positioning difficulty

  • Cardiac problems

Worry About

  • Macroglossia leading to difficult intubation

  • Valvular heart disease, cardiomyopathy

  • Stiff joints

  • Spastic paresis

  • Poor IV access

Overview

  • Described by American ophthalmologist Harold Glendon Scheie in 1962.

  • Mildest form of mucopolysaccharidosis type (1) and a rare lysosomal storage disease.

  • Pts are of normal height and do not show intellectual deficiency.

  • Corneal clouding and glaucoma.

  • Coarse facial features.

  • Normal life expectancy, stiff joints, and aortic regurgitation.

Etiology

  • Caused by mutations in genes that control production of enzyme alpha- l -iduronidase (IDUA).

  • The gene known as IDUA causes deficiency of enzymes and results in buildup of undigested mucopolysaccharidesin the cells.

  • Diagnosis occurs by elevated GAG in urine and demonstration of IDUA deficiency in leukocytes.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here